Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial

AbstractBackground:Due to increasing antimicrobial resistance, a bismuth-based quadruple regimen has been recommended as an alternative first-line therapy for Helicobacter pylori (H pylori) eradication. However, different results are varied greatly and the availability of bismuth was limited in some